92 results
Page 3 of 5
8-K
EX-10.3
0fqns 4vg
29 Jan 20
BioPharmX and Timber Pharmaceuticals Announce Entry into Merger Agreement
4:33pm
8-K
EX-10.1
7rkay
29 Jan 20
BioPharmX and Timber Pharmaceuticals Announce Entry into Merger Agreement
4:33pm
8-K
EX-10.2
pbanc5du0 rhv
29 Jan 20
BioPharmX and Timber Pharmaceuticals Announce Entry into Merger Agreement
4:33pm
425
EX-10.2
kmjhva3rmalbe9d20x1
29 Jan 20
Business combination disclosure
4:31pm
425
EX-10.4
n4jiidnustt4a28n ni1
29 Jan 20
Business combination disclosure
4:31pm
425
EX-10.3
n6ggx qa4
29 Jan 20
Business combination disclosure
4:31pm
425
EX-10.1
z2dsfj
29 Jan 20
Business combination disclosure
4:31pm
8-K
EX-10.1
u1oooiz0s0
17 Jul 19
BioPharmX Announces Steven M. Bosacki Joins the Company as Chief Operating Officer
4:12pm
8-K
EX-10.2
qnv2a9 2f
21 Mar 19
BioPharmX Announces $3.9 Million Offering
4:16pm
8-K
EX-10.1
hmm51go ifp4qv
21 Mar 19
BioPharmX Announces $3.9 Million Offering
4:16pm
8-K
EX-10.1
8v3d yluivtf9nl
21 Nov 18
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.1
ubu7dj9qa5
31 Oct 18
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-10.1
ev1zk1ydzjfjjmf
13 Sep 18
BioPharmX Corporation Announces David S. Tierney, MD Joined the Company as Chief Executive Officer
12:00am
8-K
EX-10.1
sio9fcryf83y
23 Oct 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
sk0gk9p1 orotg0
24 Jul 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
vdilq9tz0qxr2cru4uqu
26 Apr 17
BioPharmX Announces $5.0 Million Offering
12:00am
8-K
EX-10.2
b05yveaf6r9vzgbwt5w1
26 Apr 17
BioPharmX Announces $5.0 Million Offering
12:00am